Sinha Vikas's Form 4/A amendment
AmendedVerona Pharma plc (VRNA) · filed May 22, 2025
- Accession no.
- 0001104659-25-051979
- Filed
- May 22, 2025
- Trade date
- Apr 29, 2025
- Filing delay
- 23 days
- Rule 10b5-1 plan
- Checked
- Original filed
- May 1, 2025
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.43M. It was filed 23 days after the trade.
This amendment replaces 0001104659-25-043644 (filed May 1, 2025).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sinha VikasCIK 0001337845 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 29, 2025 | Ordinary Shares | MOption exerciseAcquired | +120,384 | $1.70 | +$204,652.8 | 194,824 | Direct | |
| Apr 29, 2025 | Ordinary Shares | SSaleDisposed | −120,384 | $8.92 | −$1,073,825.28 | 74,440 | Direct | |
| Apr 29, 2025 | Ordinary Shares | MOption exerciseAcquired | +39,616 | $0.50 | +$19,808 | 114,056 | Direct | |
| Apr 29, 2025 | Ordinary Shares | SSaleDisposed | −39,616 | $8.92 | −$353,374.72 | 74,440 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 29, 2025 | Ordinary Shares | MOption exerciseDisposed | −120,384 | $0.00 | $0 | 0 | Direct | |
| Apr 29, 2025 | Ordinary Shares | MOption exerciseDisposed | −39,616 | $0.00 | $0 | 160,384 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.